AR120727A1 - Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma - Google Patents

Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma

Info

Publication number
AR120727A1
AR120727A1 ARP200103449A ARP200103449A AR120727A1 AR 120727 A1 AR120727 A1 AR 120727A1 AR P200103449 A ARP200103449 A AR P200103449A AR P200103449 A ARP200103449 A AR P200103449A AR 120727 A1 AR120727 A1 AR 120727A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
preparation
same
bpi
comprises bpi
Prior art date
Application number
ARP200103449A
Other languages
English (en)
Spanish (es)
Inventor
Chengwu Yu
Xin Li
Chun Tang
Xiaoxia Zhang
Jirong Peng
Don Zhang
Yuelie Lu
Original Assignee
Beta Pharma Suzhou Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Pharma Suzhou Ltd filed Critical Beta Pharma Suzhou Ltd
Publication of AR120727A1 publication Critical patent/AR120727A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP200103449A 2019-12-11 2020-12-11 Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma AR120727A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911264353.1A CN110898026A (zh) 2019-12-11 2019-12-11 包含bpi-7711的药用组合物及其制备方法

Publications (1)

Publication Number Publication Date
AR120727A1 true AR120727A1 (es) 2022-03-09

Family

ID=69824307

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200103449A AR120727A1 (es) 2019-12-11 2020-12-11 Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma

Country Status (4)

Country Link
CN (1) CN110898026A (zh)
AR (1) AR120727A1 (zh)
TW (1) TW202122087A (zh)
WO (1) WO2021115425A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110898026A (zh) * 2019-12-11 2020-03-24 倍而达药业（苏州）有限公司 包含bpi-7711的药用组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105085489B (zh) * 2014-11-05 2019-03-01 益方生物科技（上海）有限公司 嘧啶或吡啶类化合物、其制备方法和医药用途
TW201800404A (zh) * 2016-06-17 2018-01-01 貝達醫藥公司 N-(2-(2-(二甲基胺基)乙氧基)-4-甲氧基-5-((4-(1-甲基-1h-吲哚-3-基)嘧啶-2-基)胺基)苯基)丙烯醯胺及其結晶型式之醫藥鹽
CN110799191B (zh) * 2017-06-16 2023-05-26 贝塔制药有限公司 N-(2-(2-(二甲氨基)乙氧基)-4-甲氧基-5-((4-(1-甲基-1h-吲哚-3-基)嘧啶-2-基)氨基)苯基)丙烯酰胺及其盐的药物制剂
CN110898026A (zh) * 2019-12-11 2020-03-24 倍而达药业（苏州）有限公司 包含bpi-7711的药用组合物及其制备方法

Also Published As

Publication number Publication date
WO2021115425A1 (zh) 2021-06-17
TW202122087A (zh) 2021-06-16
CN110898026A (zh) 2020-03-24

Similar Documents

Publication Publication Date Title
CR20220281A (es) Derivados de pirazolilo útiles como agentes anti-cancerígenos
MX2022015207A (es) Compuestos antivirales para tratar infecciones por coronavirus, picornavirus, y norovirus.
MX2022008066A (es) Compuestos triciclicos sustituidos.
TN2018000319A1 (en) Macrocyclic mcl1 inhibitors for treating cancer
AR125321A2 (es) Compuesto cristalino, método de preparación y composición que lo comprende
MX2022006475A (es) Compuestos triciclicos sustituidos.
BR112018002499A2 (pt) método de preparação de um composto da fórmula (a) ou um seu sal, solvato ou conjugado de aminoácido farmaceuticamente aceitável, composto produzido pelo método e composição farmacêutica
MX2022001784A (es) Piperidinil-metil-purinaminas como inhibidores de nsd2 y antineoplásicos.
CR20200116A (es) Compuestos de bisamida que activan el sarcómero y sus usos
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
DOP2024000039A (es) Derivados de quinolina como inhibidores de la integrina alfa4beta7
EA201990455A1 (ru) КОНДЕНСИРОВАННОЕ ТРИЦИКЛИЧЕСКОЕ ПРОИЗВОДНОЕ γ-АМИНОКИСЛОТЫ, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКОЕ ПРИМЕНЕНИЕ
MX2017012295A (es) Derivados formilados n-heterociclicos como inhibidores de fgfr4.
MA48798B1 (fr) Procédé de production d'ozanimod
MX2018014374A (es) Tiofeno, método de fabricación y aplicación farmacéutica del mismo.
WO2018125961A8 (en) Poly-adp ribose polymerase (parp) inhibitors
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
MX2021003662A (es) Derivado de aminonorbornano y metodo de fabricacion del mismo y uso del mismo.
MX2022005615A (es) Derivado triciclico de dihidroimidazopirimidona, metodo de preparacion del mismo, composicion farmaceutica y uso del mismo.
TN2016000491A1 (en) Carboxamide derivatives.
MX2021012105A (es) Compuestos de pirrol.
WO2020016847A3 (en) Purification process for preparation of eribulin and intermediates thereof
AR086987A1 (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
AR120727A1 (es) Composición farmacéutica que comprende bpi-7711 y método de preparación de la misma

Legal Events

Date Code Title Description
FB Suspension of granting procedure